![SI190021: Selexipag Metabolite-d8 (ACT-333679) label-new 2-[2-(2-Azidoethoxy)ethoxy]ethyl α-D-mannopyranoside](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/SI190021.svg?v=1702501701)
Pay in 4 interest-free payments of $225.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
2-[2-(2-Azidoethoxy)ethoxy]ethyl α-D-mannopyranoside
4-Methylumbelliferyl (MU) glycosides are fluorogenic enzyme substrates: cleavage of the glycosidic bond by the target enzyme releases free 4-methylumbelliferone
anti-Tn antibody
89 / Thyroid / Levothyroxine-d3 / O-(4-Hydroxy-3
SI190021: Selexipag Metabolite-d8 (ACT-333679) label-new 2-[2-(2-Azidoethoxy)ethoxy]ethyl α-D-mannopyranosideC25H21D8N3O3 427. 57 Pulmonary Hypertension Selexipag Metabolite d8 (ACT 333679) 2 {4 [(5,6 diphenylpyrazin 2 yl)(propan 2 yl)amino]butoxy} acetic acid d8
US$ 57.00
US$ 182.00
US$ 19.00
US$ 182.50
US$ 67.00
